BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 5980386)

  • 1. [Is there still justification for using streptomycin solely as a "protective drug" in surgery?].
    Lukas W
    Prax Pneumol; 1966 Dec; 20(12):748-58. PubMed ID: 5980386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of routine treatment of pulmonary tuberculosis patients treated for the 1st time].
    Bernard E; Abadi O; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):967-74. PubMed ID: 5402999
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of pulmonary tuberculosis.
    Bayliss CG
    Med J Aust; 1967 Sep; 2(10):441-4. PubMed ID: 4294059
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug-resistant pulmonary tuberculosis in Norway. Preliminary report.
    Bjartveit K
    Scand J Respir Dis Suppl; 1969; 69():21-2. PubMed ID: 5264216
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 6. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
    Burzibu JM; Durante C; Ceicu A; el Fassi el Fahri M; Bahsoun H
    Maroc Med; 1974 May; 54(579):307-13. PubMed ID: 4444314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical value of the complex determination of the drug resistance of Mycobacterium tuberculosis].
    Gur'ian IE
    Sov Med; 1973 Apr; 36(4):94-7. PubMed ID: 4203677
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of the resistance to the classical tuberculostatics].
    Eule H
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):319-24. PubMed ID: 5897859
    [No Abstract]   [Full Text] [Related]  

  • 10. [The four-fold treatment of serious forms of pulmonary tuberculosis].
    Amsler R
    Sem Ther; 1966; 42(6):365-6. PubMed ID: 5984624
    [No Abstract]   [Full Text] [Related]  

  • 11. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibacterial therapy of pulmonary tuberculosis in the Bulgarian People's Republic and possibilities of its improvement].
    Dimitrov DA
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):342-3. PubMed ID: 5897865
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of treatment of pulmonary tuberculosis under conditions of compulsory isolation].
    Zaworski C
    Gruzlica; 1967 May; 35(5):441-5. PubMed ID: 6056258
    [No Abstract]   [Full Text] [Related]  

  • 16. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of classical chemotherapy in in-patient and out-patient treatment of freshly detected pulmonary tuberculosis].
    Kuczborski S
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):339-41. PubMed ID: 5897864
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effectiveness of chemotherapy in patients with primary distructive tuberculosis].
    Novikova NA
    Probl Tuberk; 1967; 45(5):21-6. PubMed ID: 5617940
    [No Abstract]   [Full Text] [Related]  

  • 19. [Test-therapy to determine the activity of minor forms of pulmonary tuberculosis].
    Rastvortseva TN
    Probl Tuberk; 1971; 49(6):31-4. PubMed ID: 5117826
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.